Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience.
Buja P, D'Amico G, Facchin M, Barioli A, Napodano M, Capodanno D, Musumeci G, Frigo AC, Saia F, Menozzi A, De Benedictis M, Lee MS, Lettieri C, Tamburino C, Sardella G, Isabella G, Tarantini G. Buja P, et al. Among authors: barioli a. Int J Cardiol. 2013 Sep 20;168(1):139-43. doi: 10.1016/j.ijcard.2012.09.049. Epub 2012 Oct 23. Int J Cardiol. 2013. PMID: 23103143
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification.
Tarantini G, Gasparetto V, Napodano M, Frigo AC, Fraccaro C, Buja P, D'Onofrio A, D'Amico G, Barioli A, Baritussio A, Facchin M, Dariol G, Isabella G, Gerosa G, Iliceto S. Tarantini G, et al. Among authors: barioli a. Int J Cardiol. 2013 Oct 12;168(5):5001-3. doi: 10.1016/j.ijcard.2013.07.123. Epub 2013 Aug 8. Int J Cardiol. 2013. PMID: 23931971 No abstract available.
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials.
Tarantini G, Brener SJ, Barioli A, Gratta A, Parodi G, Rossini R, Navarese EP, Niccoli G, Frigo AC, Musumeci G, Iliceto S, Stone GW. Tarantini G, et al. Among authors: barioli a. Am Heart J. 2014 Mar;167(3):401-412.e6. doi: 10.1016/j.ahj.2013.11.013. Epub 2013 Dec 19. Am Heart J. 2014. PMID: 24576526
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.
Pighi M, Tomai F, Petrolini A, de Luca L, Tarantini G, Barioli A, Colombo P, Klugmann S, Ferlini M, Ormezzano MF, Loi B, Calabrò P, Bianchi RM, Faggian G, Forni A, Vassanelli C, Valgimigli M, Ribichini F. Pighi M, et al. Among authors: barioli a. J Cardiovasc Transl Res. 2016 Feb;9(1):40-8. doi: 10.1007/s12265-015-9665-x. Epub 2015 Dec 18. J Cardiovasc Transl Res. 2016. PMID: 26684009 Clinical Trial.
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.
Tarantini G, Nai Fovino L, Tellaroli P, Chieffo A, Barioli A, Menozzi A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Dominguez JF, Steffanon L, Presbitero P, Pucci E, Fraccaro C, Mauri J, Giustino G, Sardella G, Colombo A. Tarantini G, et al. Among authors: barioli a. Int J Cardiol. 2016 Mar 15;207:168-76. doi: 10.1016/j.ijcard.2016.01.068. Epub 2016 Jan 11. Int J Cardiol. 2016. PMID: 26803236 Clinical Trial.
29 results